Tecsys Reports Financial Results for the Third Quarter of Fiscal 2025
Record Revenue Quarter Led by SaaS
MONTREAL, March 5, 2025 /CNW/ -- Tecsys Inc. (TSX: TCS), an industry-leading supply chain management SaaS company, today announced its results for the third quarter of fiscal 2025, ended January 31, 2025. All dollar amounts are expressed in Canadian currency and are prepared in accordance with International Financial Reporting Standards (IFRS).
"This quarter, we achieved record revenue driven by strong growth in SaaS. We're seeing diversified activity across key sectors, from major health systems to healthcare 3PLs as well as industrial distributors. Our pharmacy supply chain solutions continue to drive strong market activity." said Peter Brereton, president and CEO of Tecsys.
Mark Bentler, chief financial officer of Tecsys, added, "We are experiencing strong momentum in our SaaS business, coupled with increasing profitability. We're pleased to see Adjusted EBITDA scaling effectively, up 33% year-to-date."
Third quarter highlights:
- SaaS revenue increased by 22% to $17.3 million, up from $14.2 million in Q3 2024.
- SaaS subscription bookingsi (measured on an ARRi basis) were $4.0 million compared to $4.9 million in the third quarter of fiscal 2024.
- SaaS Remaining Performance Obligation (RPOi) increased by 34% to $210.2 million at January 31, 2025, up from $157.2 million at the same time last year.
- Total revenue increased to a record $45.2 million compared to $43.8 million in Q3 2024.
- Net profit was $1.2 million or $0.08 per share on a fully diluted basis in Q3 2025, compared to a net profit of $0.8 million or $0.05 per share for the same period in fiscal 2024.
- Adjusted EBITDAii was $3.5 million compared to $2.6 million reported in Q3 last year.
- In the third quarter of fiscal 2025, Tecsys acquired 38,200 of its outstanding common shares for approximately $1.7 million as part of its ongoing Normal Course Issuer Bid, compared to 50,400 shares acquired in the same period last year for approximately $1.5 million.
Year-to-date performance for first nine months of fiscal 2025
- SaaS revenue increased by 29% to $48.7 million, up from $37.7 million in the same period of fiscal 2024.
- SaaS subscription bookingsi (measured on an ARRi basis) increased by 3% to $10.8 million, compared to $10.5 million in the same period of fiscal 2024.
- Total revenue increased to $129.9 million compared to $127.3 million in the same period of fiscal 2024.
- Net profit was $2.7 million ($0.19 per basic share or $0.18 per fully diluted share) in the first nine months of fiscal 2025, compared to a net profit of $1.6 million ($0.11 per basic and fully diluted share) for the same period in fiscal 2024.
- Adjusted EBITDAii was $9.1 million compared to $6.8 million reported in the same period of fiscal 2024.
- In the first nine months of fiscal 2025, Tecsys acquired 149,400 of its outstanding common shares for approximately $6.0 million as part of its ongoing Normal Course Issuer Bid, compared to 76,200 shares acquired in the same period last year for approximately $2.2 million.
Financial guidance:
Tecsys is maintaining its FY25 guidance for SaaS revenue growth of 30-32% and Adjusted EBITDA margins of 8-9% for FY25 and 10-11% for FY26. We saw strong Q3 Professional Services bookings and year-over-year growth in SaaS bookings; however, the timing of these bookings is expected to result in full-year AEBITDA margins and SaaS revenue being at the lower end of the guidance range.
Overall, based on actual third quarter hardware shipments and visibility into overall fourth quarter revenue, the Company is raising its fiscal 2025 total revenue growth guidance from flat to 1-3% growth and will provide fiscal 2026 guidance with its Q4 and full-year fiscal 2025 earnings release.
On March 5, 2025, the Company declared a quarterly dividend of $0.085 per share to be paid on April 16, 2025 to shareholders of record on March 26, 2025.
Pursuant to the Canadian Income Tax Act, dividends paid by the Company to Canadian residents are considered to be "eligible" dividends.
i See Key Performance Indicators in Management's Discussion and Analysis of the Q3 2025 Financial Statements. |
ii See Non-IFRS Performance Measures in Management's Discussion and Analysis of the Q3 2025 Financial Statements |
Q3 2025 Financial Results Conference Call
Date: March 6, 2025
Time: 8:30 a.m. ET
Phone number: 800-836-8184 or 646-357-8785
The call can be replayed until March 13, 2025, by calling:
888-660-6345 or 646-517-4150 (access code: 14330#)
About Tecsys
Tecsys is a global provider of advanced supply chain solutions. With a commitment to innovation and customer success, the company equips organizations with the essential software, technology and expertise needed for operational excellence and competitive advantage. Its cloud solutions serve a diverse range of industries, including healthcare, distribution and converging commerce, across multiple complex, regulated and high-volume markets. Built on the Itopia® low-code application platform, Tecsys' offerings include enterprise resource planning, warehouse management, consolidated service management, distribution and transportation management, supply management at the point of use and order management solutions. Tecsys provides critical data insights and control across the supply chain, ensuring that organizations are agile, responsive and scalable.
Tecsys is publicly traded on the Toronto Stock Exchange under the ticker symbol TCS. For more about Tecsys and its solutions, please visit www.tecsys.com.
Forward Looking Statements
The statements in this news release relating to matters that are not historical fact are forward-looking statements that are based on management's beliefs and assumptions. Such statements are not guarantees of future performance and are subject to a number of uncertainties, including but not limited to future economic conditions, the markets that Tecsys Inc. serves, the actions of competitors, major new technological trends, and other factors beyond the control of Tecsys Inc., which could cause actual results to differ materially from such statements. More information about the risks and uncertainties associated with Tecsys Inc.'s business can be found in the MD&A section of the Company's annual report and the most recently filed annual information form. These documents have been filed with the Canadian securities commissions and are available on our website (www.tecsys.com) and on SEDAR+ (www.sedarplus.ca).
Copyright © Tecsys Inc. 2025. All names, trademarks, products, and services mentioned are registered or unregistered trademarks of their respective owners.
Non-IFRS Measures
Reconciliation of EBITDA and Adjusted EBITDA
EBITDA is calculated as earnings before interest expense, interest income, income taxes, depreciation and amortization. Adjusted EBITDA is calculated as EBITDA before stock-based compensation and restructuring costs. The exclusion of interest expense, interest income, income taxes and restructuring costs eliminates the impact on earnings derived from non-operational activities and non-recurring items, and the exclusion of depreciation, amortization and stock-based compensation eliminates the non-cash impact of these items.
The Company believes that these measures are useful measures of financial performance without the variation caused by the impacts of the items described above and that could potentially distort the analysis of trends in our operating performance. In addition, they are commonly used by investors and analysts to measure a company's performance, its ability to service debt and to meet other payment obligations, or as a common valuation measurement. Excluding these items does not imply that they are necessarily non-recurring. Management believes these non-IFRS financial measures, in addition to conventional measures prepared in accordance with IFRS, enable investors to evaluate the Company's operating results, underlying performance and future prospects in a manner similar to management. Although EBITDA and Adjusted EBITDA are frequently used by securities analysts, lenders and others in their evaluation of companies, they have limitations as an analytical tool, and should not be considered in isolation, or as a substitute for analysis of the Company's results as reported under IFRS.
The reconciliation of EBITDA and Adjusted EBITDA to the most directly comparable IFRS measure is provided below.
Three months ended January 31, | Nine months ended January 31, | Trailing 12 months ended January 31, | ||||||||||
(in thousands of CAD) | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | ||||||
Net profit for the period | $ | 1,193 | $ | 759 | $ | 2,749 | $ | 1,590 | $ | 3,008 | $ | 2,036 |
Adjustments for: | ||||||||||||
Depreciation of property and equipment and right-of-use assets | 376 | 355 | 1,124 | 1,116 | 1,485 | 1,556 | ||||||
Amortization of deferred development costs | 190 | 147 | 585 | 436 | 732 | 581 | ||||||
Amortization of other intangible assets | 322 | 356 | 984 | 1,146 | 1,331 | 1,548 | ||||||
Interest expense | 18 | 45 | 67 | 136 | 94 | 153 | ||||||
Interest income | (150) | (260) | (530) | (782) | (763) | (993) | ||||||
Income taxes | 811 | 644 | 1,674 | 1,422 | 893 | 2,177 | ||||||
EBITDA | $ | 2,760 | $ | 2,046 | $ | 6,653 | $ | 5,064 | $ | 6,780 | $ | 7,058 |
Adjustments for: | ||||||||||||
Stock based compensation | 775 | 594 | 2,415 | 1,770 | 2,946 | 2,225 | ||||||
Restructuring costs | - | - | - | - | 2,122 | - | ||||||
Adjusted EBITDAii | $ | 3,535 | $ | 2,640 | $ | 9,068 | $ | 6,834 | $ | 11,848 | $ | 9,283 |
Condensed Interim Consolidated Statements of Financial Position (In thousands of Canadian dollars) | ||||
January 31, 2025 | April 30, 2024 | |||
Assets | ||||
Current assets | ||||
Cash and cash equivalents | $ | 20,970 | $ | 18,856 |
Short-term investments | 11,614 | 16,713 | ||
Accounts receivable | 21,563 | 22,090 | ||
Work in progress | 7,060 | 4,248 | ||
Other receivables | 189 | 134 | ||
Tax credits | 5,365 | 6,422 | ||
Inventory | 1,937 | 1,359 | ||
Prepaid expenses and other | 9,756 | 9,143 | ||
Total current assets | 78,454 | 78,965 | ||
Non-current assets | ||||
Other long-term receivables and assets | 640 | 421 | ||
Tax credits | 6,757 | 4,737 | ||
Property and equipment | 1,068 | 1,372 | ||
Right-of-use assets | 934 | 1,251 | ||
Contract acquisition costs | 4,610 | 4,478 | ||
Deferred development costs | 3,430 | 2,683 | ||
Other intangible assets | 6,833 | 7,703 | ||
Goodwill | 17,517 | 17,363 | ||
Deferred tax assets | 9,073 | 9,073 | ||
Total non-current assets | 50,862 | 49,081 | ||
Total assets | $ | 129,316 | $ | 128,046 |
Liabilities | ||||
Current liabilities | ||||
Accounts payable and accrued liabilities | 24,677 | 20,030 | ||
Deferred revenue | 38,684 | 36,211 | ||
Lease obligations | 732 | 812 | ||
Total current liabilities | 64,093 | 57,053 | ||
Non-current liabilities | ||||
Other long-term accrued liabilities | 3,886 | 496 | ||
Deferred tax liabilities | 552 | 826 | ||
Lease obligations | 783 | 1,302 | ||
Total non-current liabilities | 5,221 | 2,624 | ||
Total liabilities | $ | 69,314 | $ | 59,677 |
Equity | ||||
Share capital | $ | 53,788 | $ | 52,256 |
Contributed surplus | 5,877 | 9,417 | ||
Retained earnings | 7,251 | 8,121 | ||
Accumulated other comprehensive loss | (6,914) | (1,425) | ||
Total equity attributable to the owners of the Company | 60,002 | 68,369 | ||
Total liabilities and equity | $ | 129,316 | $ | 128,046 |
Condensed Interim Consolidated Statements of Income and Comprehensive (Loss) Income (In thousands of Canadian dollars, except per share data) | ||||||||
Three Months Ended January 31, | Nine Months Ended January 31, | |||||||
2025 | 2024 | 2025 | 2024 | |||||
Revenue: | ||||||||
SaaS | $ | 17,252 | $ | 14,160 | $ | 48,696 | $ | 37,727 |
Maintenance and Support | 8,142 | 8,620 | 24,560 | 25,817 | ||||
Professional Services | 13,920 | 13,021 | 41,452 | 40,798 | ||||
License | 212 | 396 | 1,517 | 1,104 | ||||
Hardware | 5,655 | 7,626 | 13,674 | 21,841 | ||||
Total revenue | 45,181 | 43,823 | 129,899 | 127,287 | ||||
Cost of revenue | 23,907 | 23,893 | 68,449 | 69,512 | ||||
Gross profit | 21,274 | 19,930 | 61,450 | 57,775 | ||||
Operating expenses: | ||||||||
Sales and marketing | 9,053 | 8,223 | 26,457 | 24,539 | ||||
General and administration | 3,096 | 2,650 | 9,273 | 8,580 | ||||
Research and development, net of tax credits | 7,114 | 7,834 | 21,650 | 22,079 | ||||
Total operating expenses | 19,263 | 18,707 | 57,380 | 55,198 | ||||
Profit from operations | 2,011 | 1,223 | 4,070 | 2,577 | ||||
Other (costs) income | (7) | 180 | 353 | 435 | ||||
Profit before income taxes | 2,004 | 1,403 | 4,423 | 3,012 | ||||
Income tax expense | 811 | 644 | 1,674 | 1,422 | ||||
Net profit | $ | 1,193 | $ | 759 | $ | 2,749 | $ | 1,590 |
Other comprehensive (loss) income: | ||||||||
Effective portion of changes in fair value on designated revenue hedges | (5,188) | 4,101 | (5,721) | 1,101 | ||||
Exchange differences on translation of foreign operations | (90) | (90) | 232 | (424) | ||||
Comprehensive (loss) income | $ | (4,085) | $ | 4,770 | $ | (2,740) | $ | 2,267 |
Basic earnings per common share | $ | 0.08 | $ | 0.05 | $ | 0.19 | $ | 0.11 |
Diluted earnings per common share | $ | 0.08 | $ | 0.05 | $ | 0.18 | $ | 0.11 |
Condensed Interim Consolidated Statements of Cash Flows (In thousands of Canadian dollars) | ||||||||
Three Months Ended January 31, | Nine Months Ended January 31, | |||||||
2025 | 2024 | 2025 | 2024 | |||||
Cash flows from operating activities: | ||||||||
Net profit | $ | 1,193 | $ | 759 | $ | 2,749 | $ | 1,590 |
Adjustments for: | ||||||||
Depreciation of property and equipment and right-of-use-assets | 376 | 355 | 1,124 | 1,116 | ||||
Amortization of deferred development costs | 190 | 147 | 585 | 436 | ||||
Amortization of other intangible assets | 322 | 356 | 984 | 1,146 | ||||
Interest (income) expense and foreign exchange loss | 7 | (180) | (353) | (435) | ||||
Unrealized foreign exchange and other | 516 | (452) | 599 | (1,050) | ||||
Non-refundable tax credits | (1,008) | (151) | (1,942) | (1,365) | ||||
Stock-based compensation | 775 | 594 | 2,415 | 1,770 | ||||
Income taxes | 34 | 78 | 221 | 454 | ||||
Net cash from operating activities excluding changes in non-cash working capital items related to operations | 2,405 | 1,506 | 6,382 | 3,662 | ||||
Accounts receivable | 269 | (4,175) | 571 | (1,950) | ||||
Work in progress | (2,563) | 557 | (2,804) | (1,662) | ||||
Other receivables and assets | 90 | 184 | (346) | 136 | ||||
Tax credits | 3,338 | 3,160 | 979 | 841 | ||||
Inventory | 178 | 213 | (576) | (871) | ||||
Prepaid expenses | (1,534) | (304) | (571) | (945) | ||||
Contract acquisition costs | (251) | (401) | (171) | (261) | ||||
Accounts payable and accrued liabilities | 3,111 | 3,890 | 1,111 | 597 | ||||
Deferred revenue | 1,764 | (2,295) | 2,455 | 327 | ||||
Changes in non-cash working capital items related to operations | 4,402 | 829 | 648 | (3,788) | ||||
Net cash provided by (used in) operating activities | 6,807 | 2,335 | 7,030 | (126) | ||||
Cash flows from financing activities: | ||||||||
Payment of lease obligations | (205) | (195) | (607) | (593) | ||||
Payment of dividends | (1,251) | (1,177) | (3,619) | (3,385) | ||||
Interest paid | (18) | (45) | (67) | (136) | ||||
Issuance of common shares on exercise of stock options | 971 | 423 | 1,568 | 3,067 | ||||
Shares repurchased and cancelled | (1,679) | (1,532) | (5,991) | (2,205) | ||||
Net cash used in financing activities | (2,182) | (2,526) | (8,716) | (3,252) | ||||
Cash flows from investing activities: | ||||||||
Interest received | 32 | 22 | 59 | 91 | ||||
Transfers from short-term investments | - | 18 | 5,570 | 40 | ||||
Acquisitions of property and equipment | (88) | (190) | (497) | (455) | ||||
Deferred development costs | (447) | (309) | (1,332) | (809) | ||||
Net cash (used in) provided by investing activities | (503) | (459) | 3,800 | (1,133) | ||||
Net increase (decrease) in cash and cash equivalents during the period | 4,122 | (650) | 2,114 | (4,511) | ||||
Cash and cash equivalents - beginning of period | 16,848 | 17,374 | 18,856 | 21,235 | ||||
Cash and cash equivalents - end of period | $ | 20,970 | $ | 16,724 | $ | 20,970 | $ | 16,724 |
Condensed Interim Consolidated Statements of Changes in Equity (In thousands of Canadian dollars, except number of shares) | |||||||||||
Share capital | Contributed |
Accumulated other | Retained | Total | |||||||
Number | Amount | ||||||||||
Balance, May 1, 2024 | 14,840,150 | $ | 52,256 | $ | 9,417 | $ | (1,425) | $ | 8,121 | $ | 68,369 |
Net profit | - | - | - | - | 2,749 | 2,749 | |||||
Other comprehensive (loss) income: | |||||||||||
Effective portion of changes in fair value on designated revenue hedges | - | - | - | (5,721) | - | (5,721) | |||||
Exchange difference on translation of foreign operations | - | - | - | 232 | - | 232 | |||||
Total comprehensive (loss) income | - | - | - | (5,489) | 2,749 | (2,740) | |||||
Shares repurchased and cancelled | (149,400) | (531) | (5,460) | - | - | (5,991) | |||||
Stock-based Compensation | - | - | 2,415 | - | - | 2,415 | |||||
Dividends to equity owners | - | - | - | - | (3,619) | (3,619) | |||||
Share options exercised | 53,337 | 2,063 | (495) | - | - | 1,568 | |||||
Total transactions with owners of the Company | (96,063) | $ | 1,532 | $ | (3,540) | $ | - | $ | (3,619) | $ | (5,627) |
Balance, January 31, 2025 | 14,744,087 | $ | 53,788 | $ | 5,877 | $ | (6,914) | $ | 7,251 | $ | 60,002 |
Balance, May 1, 2023 | 14,582,837 | $ | 44,338 | 15,285 | $ | (17) | $ | 10,832 | $ | 70,438 | |
Net profit | - | - | - | - | 1,590 | 1,590 | |||||
Other comprehensive income: | - | ||||||||||
Effective portion of changes in fair value on designated revenue hedges | - | - | - | 1,101 | - | 1,101 | |||||
Exchange difference on translation of foreign operations | - | - | - | (424) | - | (424) | |||||
Total comprehensive income | - | - | - | 677 | 1,590 | 2,267 | |||||
Shares repurchased and cancelled | (76,200) | (248) | (1,957) | - | - | (2,205) | |||||
Stock-based Compensation | - | - | 1,770 | - | - | 1,770 | |||||
Dividends to equity owners | - | - | - | - | (3,385) | (3,385) | |||||
Share options exercised | 192,302 | 3,936 | (869) | - | - | 3,067 | |||||
Total transactions with owners of the Company | 116,102 | $ | 3,688 | $ | (1,056) | $ | - | $ | (3,385) | $ | (753) |
Balance, January 31, 2024 | 14,698,939 | $ | 48,026 | $ | 14,229 | $ | 660 | $ | 9,037 | $ | 71,952 |
SOURCE Tecsys Inc.
Nachrichten zu The Container Store Group Inc
Analysen zu The Container Store Group Inc
| Datum | Rating | Analyst | |
|---|---|---|---|
| 24.05.2017 | The Container Store Group Equal Weight | Barclays Capital |
| Datum | Rating | Analyst | |
|---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv | |||
| Datum | Rating | Analyst | |
|---|---|---|---|
| 24.05.2017 | The Container Store Group Equal Weight | Barclays Capital |
| Datum | Rating | Analyst | |
|---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv | |||
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für The Container Store Group Inc nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen